(Q37434517)

20 August 2017

1 reference

title

Seasonal influenza vaccines: evolutions and future trends (English)

1 reference

20 August 2017

1 reference

1

Arnold S Monto

1 reference

20 August 2017

2

Suzanne E Ohmit

1 reference

20 August 2017

language of work or name

1 reference

1 April 2009

1 reference

Expert Review of Vaccines

20 August 2017

published in

1 reference

20 August 2017

volume

8

1 reference

20 August 2017

issue

4

1 reference

20 August 2017

page(s)

383-389

1 reference

ANTIBODY RESPONSE OF HUMAN BEINGS FOLLOWING VACCINATION WITH INFLUENZA VIRUSES.

20 August 2017

cites work

1 reference

CLINICAL TRIALS OF OIL-ADJUVANT INFLUENZA VACCINES, 1960-3. REPORT TO THE MEDICAL RESEARCH COUNCIL BY ITS COMMITTEE ON INFLUENZA AND OTHER RESPIRATORY VIRUS VACCINES.

21 January 2018

1 reference

Recycling of Asian and Hong Kong influenza A virus hemagglutinins in man

21 January 2018

1 reference

MF59 is a safe and potent vaccine adjuvant that enhances protection against influenza virus infection.

21 January 2018

1 reference

Antigen sparing and cross-reactive immunity with an adjuvanted rH5N1 prototype pandemic influenza vaccine: a randomised controlled trial.

21 January 2018

1 reference

Cross-reactivity to highly pathogenic avian influenza H5N1 viruses after vaccination with nonadjuvanted and MF59-adjuvanted influenza A/Duck/Singapore/97 (H5N3) vaccine: a potential priming strategy.

21 January 2018

1 reference

Cross-protection against lethal H5N1 challenge in ferrets with an adjuvanted pandemic influenza vaccine

21 January 2018

1 reference

Safety of High Doses of Influenza Vaccine and Effect on Antibody Responses in Elderly Persons

21 January 2018

1 reference

Modified M2 proteins produce heterotypic immunity against influenza A virus.

21 January 2018

1 reference

A universal influenza A vaccine based on the extracellular domain of the M2 protein

21 January 2018

1 reference

A clinical trial of a whole-virus H5N1 vaccine derived from cell culture.

21 January 2018

1 reference

A Hong Kong influenza immunity three years after immunization

21 January 2018

1 reference

Efficacy of vaccination with live attenuated, cold-adapted, trivalent, intranasal influenza virus vaccine against a variant (A/Sydney) not contained in the vaccine

21 January 2018

1 reference

Live attenuated versus inactivated influenza vaccine in infants and young children.

21 January 2018

1 reference

Prevention of antigenically drifted influenza by inactivated and live attenuated vaccines

21 January 2018

1 reference

Influenza vaccine effectiveness in preventing hospitalization for pneumonia in the elderly

21 January 2018

1 reference

Clinical effectiveness of influenza vaccination in Manitoba

21 January 2018

1 reference

Effectiveness of influenza vaccine in the community-dwelling elderly

21 January 2018

1 reference

Mortality benefits of influenza vaccination in elderly people: an ongoing controversy

21 January 2018

1 reference

Functional status is a confounder of the association of influenza vaccine and risk of all cause mortality in seniors

21 January 2018

1 reference

Detection and control of influenza outbreaks in well-vaccinated nursing home populations

21 January 2018

1 reference

Safety and immunogenicity of an inactivated subvirion influenza A (H5N1) vaccine.

21 January 2018

1 reference

Cellular immune responses in children and adults receiving inactivated or live attenuated influenza vaccines

21 January 2018

1 reference

Prevention of symptomatic seasonal influenza in 2005-2006 by inactivated and live attenuated vaccines

21 January 2018

1 reference

Scientific and ethical issues in equivalence trials

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1586/ERV.09.9

1 reference

20 August 2017

1 reference